Our capacity across the network already stands at approximately 150M units and will scale to more than 200M units by 2025
What are "GLP-1 babies?" GLP-1 babies is a term used to describe surprise pregnancies in people taking GLP-1 medications, sometimes even while on birth control or after past fertility struggles
The new generation of appetite-suppressing drugs using GLP-1 agonists which include the brands Ozempic, Wegovy and Mounjaro have exploded in popularity in recent years due to their ability to help people lose weight
While all GLP-1 drugs influence appetite and metabolism, only some (like semaglutide and tirzepatide) are FDA-approved specifically for weight management
Yes, certain GLP-1 receptor agonists (liraglutide, injectable semaglutide and dulaglutide) have demonstrated cardiovascular benefits in major trials, including reduced risk of heart attack, stroke and cardiovascular death in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors